G Medical Innovations Performance
| GMVDDelisted Stock | USD 0.33 0.01 2.94% |
The firm retains a Market Volatility (i.e., Beta) of -0.0508, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning G Medical are expected to decrease at a much lower rate. During the bear market, G Medical is likely to outperform the market. G Medical Innovations today retains a risk of 0.0%. Please check out G Medical value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if G Medical will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days G Medical Innovations has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, G Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 6 M |
GMVD |
G Medical Relative Risk vs. Return Landscape
If you would invest 33.00 in G Medical Innovations on August 31, 2024 and sell it today you would earn a total of 0.00 from holding G Medical Innovations or generate 0.0% return on investment over 90 days. G Medical Innovations is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than GMVD, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
G Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for G Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as G Medical Innovations, and traders can use it to determine the average amount a G Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GMVD |
Based on monthly moving average G Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of G Medical by adding G Medical to a well-diversified portfolio.
G Medical Fundamentals Growth
GMVD Stock prices reflect investors' perceptions of the future prospects and financial health of G Medical, and G Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GMVD Stock performance.
| Return On Equity | -8.65 | |||
| Return On Asset | -2.23 | |||
| Operating Margin | (6.20) % | |||
| Current Valuation | 5.92 M | |||
| Shares Outstanding | 9.82 M | |||
| Price To Book | 6.09 X | |||
| Price To Sales | 0.48 X | |||
| Revenue | 4.42 M | |||
| EBITDA | (37.75 M) | |||
| Cash And Equivalents | 6.03 M | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 2.09 M | |||
| Debt To Equity | 0.44 % | |||
| Book Value Per Share | (4.82) X | |||
| Cash Flow From Operations | (18.48 M) | |||
| Earnings Per Share | (18.76) X | |||
| Total Asset | 4.83 M | |||
| Retained Earnings | (115.26 M) | |||
About G Medical Performance
By analyzing G Medical's fundamental ratios, stakeholders can gain valuable insights into G Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if G Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if G Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company was incorporated in 2014 and is based in Rehovot, Israel. G Medical is traded on NASDAQ Exchange in the United States.Things to note about G Medical Innovations performance evaluation
Checking the ongoing alerts about G Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for G Medical Innovations help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| G Medical is not yet fully synchronised with the market data | |
| G Medical has some characteristics of a very speculative penny stock | |
| G Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.42 M. Net Loss for the year was (25.07 M) with profit before overhead, payroll, taxes, and interest of 1.5 M. | |
| G Medical Innovations currently holds about 6.03 M in cash with (18.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 15.0% of the company shares are held by company insiders |
- Analyzing G Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether G Medical's stock is overvalued or undervalued compared to its peers.
- Examining G Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating G Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of G Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of G Medical's stock. These opinions can provide insight into G Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in GMVD Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |